CIK 0001395937
- Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320162505
- Phone
- +1 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-03-08 | MPM BioVentures IV QP LP 10% owner | Conversion | +1,138,210 | 1,138,210 | ||
| 2016-03-08 | MPM BioVentures IV QP LP 10% owner | Conversion | +718,396 | 1,856,606 | ||
| 2016-03-08 | MPM BioVentures IV QP LP 10% owner | Conversion | +312,085 | 2,168,691 | ||
| 2016-03-08 | MPM BioVentures IV QP LP 10% owner | Conversion · Series A-1 Preferred Stock | −1,138,210 | 0 | ||
| 2016-03-08 | MPM BioVentures IV QP LP 10% owner | Conversion · Series B-1 Preferred Stock | −718,396 | 0 | ||
| 2016-03-08 | MPM BioVentures IV QP LP 10% owner | Conversion · Series C-1 Preferred Stock | −312,085 | 0 | ||
| 2016-03-08 | ROYSTON IVOR Director | Conversion | +315,195 | 315,195 | ||
| 2016-03-08 | ROYSTON IVOR Director | Conversion | +198,931 | 514,126 | ||
| 2016-03-08 | ROYSTON IVOR Director | Conversion | +86,419 | 600,545 | ||
| 2016-03-08 | ROYSTON IVOR Director | Purchase | +150,000 | $12.00 | $1.8M | 750,545 |
| 2016-03-08 | ROYSTON IVOR Director | Conversion · Series A-1 Preferred Stock | −315,195 | 0 | ||
| 2016-03-08 | ROYSTON IVOR Director | Conversion · Series B-1 Preferred Stock | −198,931 | 0 | ||
| 2016-03-08 | ROYSTON IVOR Director | Conversion · Series C-1 Preferred Stock | −86,419 | 0 | ||
| 2016-03-08 | EVNIN LUKE Director | Conversion | +1,138,210 | 1,138,210 | ||
| 2016-03-08 | EVNIN LUKE Director | Conversion | +718,396 | 1,856,606 | ||
| 2016-03-08 | EVNIN LUKE Director | Conversion | +312,085 | 2,168,691 | ||
| 2016-03-08 | EVNIN LUKE Director | Conversion · Series A-1 Preferred Stock | −1,138,210 | 0 | ||
| 2016-03-08 | EVNIN LUKE Director | Conversion · Series B-1 Preferred Stock | −718,396 | 0 | ||
| 2016-03-08 | EVNIN LUKE Director | Conversion · Series C-1 Preferred Stock | −312,085 | 0 | ||
| 2016-03-08 | DP VI Associates, L.P. Director | Conversion | +13,925 | 13,925 |
Page 27 of 28 · 550 trades